Fig. 2From: Phase II study of stereotactic body radiotherapy with hydrogel spacer for prostate cancer: acute toxicity and propensity score-matched comparisonTime course of IPSS and patient-reported outcomes score a IPSS, b EPIC summary score, c EPIC subscale score. *P < 0.05 comparison between baseline and each time point. IPSS International Prostate Symptom Score, EPIC Expanded Prostate Cancer Index CompositeBack to article page